Skip to Main Content

Author Details

Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
1989
54
37
PMIDPaper TitleJournal TitlePublished Year
36831452Hypoxia-Driven TGFβ Modulation of Side Population Cells in Breast Cancer: The Potential Role of ERα.Cancers (Basel)2023
36831452Hypoxia-Driven TGFβ Modulation of Side Population Cells in Breast Cancer: The Potential Role of ERα.Cancers (Basel)2023
34860981Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban.J Pharm Technol2019
34860981Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban.J Pharm Technol2019
25515650Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.Pigment Cell Melanoma Res2015
25515650Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.Pigment Cell Melanoma Res2015
26080861Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.Nat Commun2015
26080861Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.Nat Commun2015
23633104Molecular profiling of sinonasal undifferentiated carcinoma.Head Neck2014
23633104Molecular profiling of sinonasal undifferentiated carcinoma.Head Neck2014
24993095Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.Tumour Biol2014
24559118A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.BMC Cancer2014
25056119The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF.Cancer Res2014
25193510A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.Mol Cancer Ther2014
25193510A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.Mol Cancer Ther2014
25056119The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF.Cancer Res2014
24993095Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.Tumour Biol2014
24559118A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.BMC Cancer2014
23172680Correlations between the dielectric properties and exterior morphology of cells revealed by dielectrophoretic field-flow fractionation.Electrophoresis2013
23776098Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.Mol Carcinog2013
24403990Dielectrophoresis has broad applicability to marker-free isolation of tumor cells from blood by microfluidic systems.Biomicrofluidics2013
24403989Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis.Biomicrofluidics2013
24113773Inferring tumour purity and stromal and immune cell admixture from expression data.Nat Commun2013
23174937Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.Mod Pathol2013
23172680Correlations between the dielectric properties and exterior morphology of cells revealed by dielectrophoretic field-flow fractionation.Electrophoresis2013
24403990Dielectrophoresis has broad applicability to marker-free isolation of tumor cells from blood by microfluidic systems.Biomicrofluidics2013
24403989Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis.Biomicrofluidics2013
24113773Inferring tumour purity and stromal and immune cell admixture from expression data.Nat Commun2013
23776098Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.Mol Carcinog2013
23174937Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.Mod Pathol2013
22146979Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.J Cancer Res Clin Oncol2012
22538770Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.Breast Cancer Res Treat2012
22683778Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.Nat Med2012
22422301Systematic analysis of genotype-specific drug responses in cancer.Int J Cancer2012
22419365Detection algorithm for the validation of human cell lines.Int J Cancer2012
22487539Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.Gynecol Oncol2012
22521545Breast cancer, side population cells and ABCG2 expression.Cancer Lett2012
22817889A landscape of driver mutations in melanoma.Cell2012
23028188Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.Genome Res2012
22236444Genetic and molecular characterization of uveal melanoma cell lines.Pigment Cell Melanoma Res2012
22146979Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.J Cancer Res Clin Oncol2012
22130161Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma.J Immunother2012
22151725Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy.Cancer Sci2012
23028188Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.Genome Res2012
22683778Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.Nat Med2012
22817889A landscape of driver mutations in melanoma.Cell2012
22538770Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.Breast Cancer Res Treat2012
22521545Breast cancer, side population cells and ABCG2 expression.Cancer Lett2012
22487539Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.Gynecol Oncol2012
22236444Genetic and molecular characterization of uveal melanoma cell lines.Pigment Cell Melanoma Res2012
  • 1 - 50 of 108

Recommended Authors

Dylan Nelson
Oregon State University
Career Start Year 2011
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 4
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 2
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 23
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 5
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 22
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 3
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 2
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 16
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 13
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 9
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 9
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 6
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 13
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 28
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 9
Nisha Kanwar
University of Toronto, the Hospital for Sick Children.
Career Start Year 1989
Number of shared co-authors 0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 6
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 18
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 9
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 7
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 25
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 3
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 4
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 5
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 3
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 11

Collaborators

Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 29
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Zhenlin Ju
Co-authored papers 5
Yiling Lu
Co-authored papers 5
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Joe W Gray
Oregon Health and Science University
Co-authored papers 3
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Xiaomu Wei
Cornell University
Co-authored papers 2
Ian R Watson
Co-authored papers 2
Jimmy C Lin
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 2
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 2
Chen Hu
Johns Hopkins University School of Medicine
Co-authored papers 2
Vijay Walia
National Center for Toxicological Research
Co-authored papers 2
Todd D Prickett
National Cancer Institute
Co-authored papers 2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 2
William F Symmans
Co-authored papers 2
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 2
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Steven E Scherer
Baylor College of Medicine
Co-authored papers 2
Liren Li
Co-authored papers 2
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 2
Han Liang
MD Anderson Cancer Center
Co-authored papers 2
Lajos Pusztai
Co-authored papers 2
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 2
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 2
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 2
Wenbin Liu
Co-authored papers 2
Release 1.2